Search the web
Welcome, Guest
[Sign Out, My Account]

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
ADMP > SEC Filings for ADMP > Form 8-K on 19-Mar-2013All Recent SEC Filings

Show all filings for ADAMIS PHARMACEUTICALS CORP | Request a Trial to NEW EDGAR Online Pro



Entry into a Material Definitive Agreement, Financial Statements and

Item 1.01 Entry Into a Material Definitive Agreement.

As previously disclosed on its Current Report on Form 8-K filed June 15, 2012, Adamis Pharmaceuticals Corporation (the "Company") entered into a private placement financing transaction with Gemini Master Fund, Ltd. Pursuant to the financing, the Company issued 10% Senior Convertible Note dated June 11, 2012 (the "Note"), in the aggregate original principal amount of $500,000 and 500,000 shares of common stock, and received gross proceeds of $500,000, excluding transaction costs and expenses. The Note was convertible into shares of the Company's common stock at any time at the discretion of the investor at an initial conversion price per share of $0.55. Principal and unpaid interest under the Note was due and payable nine months after the date of the Note.

On March 18, 2013, the Company and Gemini amended the Note effective as of March 11, 2013, to extend the maturity date of the Note to July 11, 2013. Interest will continue to accrue and be paid on the outstanding Note. No other changes were made to the Note or agreements relating to the Note, and all other provisions of the Note and other agreements continue in full force and effect.

Item 9.01 Financial Statements and Exhibits.

(c) Exhibits.


  Add ADMP to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for ADMP - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now

Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.